Activest Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Activest Wealth Management’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.12K	Sell	5 -81	-94%	-$55.1K	﹤0.01%	786
2026 Q1	$66.4K	Buy	86 +18	+26%	+$13.8K	0.01%	289
2025 Q4	$52.5K	Buy	68 +30	+79%	+$20.4K	0.01%	310
2025 Q3	$21.4K	Buy	38 +17	+81%	+$9.61K	﹤0.01%	369
2025 Q2	$11K	Sell	21 -19	-48%	-$10.6K	﹤0.01%	414
2025 Q1	$25.4K	Buy	40 +21	+111%	+$14.4K	0.01%	260
2024 Q4	$13.5K	Sell	19 -6	-24%	-$5.04K	﹤0.01%	284
2024 Q3	$26.2K	Buy	25 +7	+39%	+$7.79K	0.01%	224
2024 Q2	$18.9K	Buy	+18	New	+$17.4K	0.01%	242
2023 Q3	–	Sell	-51	Closed	-$40.1K	–	385
2023 Q2	$40K	Buy	+51	New	+$39.3K	0.03%	88

Other funds holding REGN

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

MCI

McDonald Capital Investors Orinda, California $1.37B AUM 1.88% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return

Activest Wealth Management's REGN Position: Q2 2026 in Review

Activest Wealth Management reduced its Regeneron Pharmaceuticals (REGN) stake by 94% in Q2 2026, selling an estimated $55.1K and leaving 5 shares worth $3.12K. The position accounts for ﹤0.01% of the portfolio, ranked #786.

Activest Wealth Management first reported a position in REGN in Q2 2023 and has held it in 10 quarters since. The position peaked at $66.4K in Q1 2026. 454 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

Activest Wealth Management held 5 shares of Regeneron Pharmaceuticals worth $3.12K as of Q2 2026.
Activest Wealth Management sold 81 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $55.1K.
Regeneron Pharmaceuticals made up ﹤0.01% of Activest Wealth Management's portfolio in Q2 2026, its #786 holding.
Activest Wealth Management first reported a position in Regeneron Pharmaceuticals in Q2 2023 and has held it in 10 quarters since.
Activest Wealth Management's Regeneron Pharmaceuticals position peaked at $66.4K in Q1 2026.
454 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Activest Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.